Trials / Completed
CompletedNCT00538525
Phase II Study of Neoadjuvant Chemotherapy With Doxorubicin Followed by Docetaxel-Cisplatin in Locally Advanced Breast Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- King Faisal Specialist Hospital & Research Center · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Phase II study of neoadjuvant chemotherapy with Doxorubicin followed by Docetaxel-Cisplatin in locally advanced breast cancer
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Doxorubicin, Docetaxel, Cisplatin | Doxorubicin, Docetaxel, Cisplatin |
Timeline
- Start date
- 2007-09-01
- Primary completion
- 2008-04-01
- Completion
- 2008-04-01
- First posted
- 2007-10-02
- Last updated
- 2012-05-30
Source: ClinicalTrials.gov record NCT00538525. Inclusion in this directory is not an endorsement.